EU/US collaboration should help future device regulation
This article was originally published in Clinica
Closer co-operation between the EU and US should benefit the medical devices and diagnostics industries considerably, as each market provides information and support that could help the other. In particular, the development of forthcoming EU legislation on human tissues will benefit from this collaboration.
You may also be interested in...
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.
Stada has appointed a head of digital communications; PGEU elects new chair and vice-chair; and the new UK health claims committee unveils its first members.